| Pfizer | 2 | The Data Requested is out of scope of data sharing policy | Identification of Research Common Data Elements in HIV/AIDS using data science methods | 3244 |
| Pfizer | 1 | The Data requested is unavailable | Predicting Treatment Response to Tumor Necrosis Factor Inhibitors in Patients with Ankylosing Spondylitis | 3369 |
| Boehringer Ingelheim | 1 | Document not available in English | Risk and Benefit Stratification of Treatment Effects in Patients with Atrial Fibrillation | 3876 |
| Eli Lilly | 5 | The data contributor or sponsor doesn't have the legal authority to provide the data | Tolerability of duloxetine in the elderly and in adults: a systematic review and individual patient data meta-analysis of randomized controlled trials versus placebo. | 4112 |
| Boehringer Ingelheim | 2 | The data requested is not appropriate for the research proposal in the Data Request | Predictors of therapeutic and adverse effects of medicines used in the treatment of breast cancer | 5289 |
| UCB | 1 | Data collected subject to legal, contractual or consent provisions that prevent further sharing of clinical data | Antiepileptic drug monotherapy for epilepsy: an updated Cochrane review and individual participant data network meta-analysis | 5291 |
| AbbVie | 1 | There is a reasonable likelihood that a patient could be re-identified | Sharing of Progressive Supranuclear Palsy (PSP) data with the Rare Disease Cures Accelerator - Data and Analytics Platform for Analysis of Outcome Measures and Other Purposes | 5989 |
| Roche | 1 | The Data Requested is out of scope of data sharing policy | Predictors of therapeutic and adverse effects of medicines used in the treatment of breast cancer | 5289 |
| Pfizer | 1 | The data requested is unavailable | Comparative efficacy and tolerability of new-generation antidepressants for major depressive disorder in children and adolescents: protocol of an individual patient data meta-analysis | 4324 |
| Pfizer | 3 | The data requested is unavailable | Inferential reproducibility of therapeutic research: a registered report for a cross-sectional study of RCTs available on major data-sharing platforms | 6055 |
| Boehringer Ingelheim | 1 | The data contributor or sponsor doesn't have the legal authority to provide the data | Assessing heterogeneity in relative treatment efficacy by age, sex and comorbidity. | 5483 |
| GlaxoSmithKline | 1 | The data requested is unavailable | Tositumomab: statistical modeling of expanded access programs and conventional trials | 6477 |
| AbbVie | 1 | There is a reasonable likelihood that a patient could be re-identified (due to the very small number of patients) | Exploring the heterogeneity of cognitive profile in patients with Progressive Supranuclear Palsy (PSP) enrolled in the ABBV-8E12 trial and the relationship to brain volumes | 7147 |
| AstraZeneca | 1 | The Data Request competes with the data contributor/sponsor's publication/dissemination plan | Evaluation of available statistical methods performance under non-proportional hazards | 6483 |
| Roche | 2 | The data requested is unavailable | Predictors of therapeutic and adverse effects of medicines used in the treatment of breast cancer | 5289, 6499 |
| AstraZeneca | 1 | Out of Scope of Data Contributor’s Data Sharing Policy | Predictors of therapeutic and adverse effects of medicines used in the treatment of breast cancer | 5289, 6499 |
| UCB | 1 | Data collected subject to legal, contractual or consent provisions that prevent further sharing of clinical data | Real time monitoring of individual response to antiseizure medication treatment during clinical trials | 7161 |
| Roche | 2 | Studies where data sharing is prohibited by the consent, legal, regulatory, or contractual constraints on data sharing. | Evaluating the association between proteinuria and thrombosis and its predictors in patients treated with Bevacizumab | 6066 |
| Abbvie | 1 | The data requested is not appropriate for the research proposal in the Data Request | Disease‐modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta-analysis incorporating individual patient data | 5987 |
| AstraZeneca | 1 | Studies where data sharing is prohibited by the consent, legal, regulatory, or contractual constraints on data sharing | Exploration of regional heterogeneity in trials assessing the efficacy of recent non-insulin glucose lowering drugs on cardiovascular outcomes
| 6593 |
| AstraZeneca | 4 | Study cannot be shared this time due to ongoing regulatory activities | Summarising the therapeutic and adverse effects of anticancer medicines according to race and sex: pooled analysis of clinical trials of contemporary treatments for solid tumours | 7667 |
| Pfizer | 3 | The data requested is not appropriate for the research proposal in the Data Request | Summarising the therapeutic and adverse effects of anticancer medicines according to race and sex: pooled analysis of clinical trials of contemporary treatments for solid tumours | 7667 |
| AstraZeneca | 1 | The data requested cannot be shared due to ongoing regulatory activities | Evaluating Clinical Trial Data Conventions for the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) | 6869 |
| GlaxoSmithKline | 1 | The Data Request required data that was not collected in the studies requested | Evaluating Clinical Trial Data Conventions for the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) | 6869 |
| UCB | 1 | The Data Request did not meet the data contributor/sponsor policies for informed consent | What are the re-identification risk scores of publicly available anonymised clinical trial datasets? | 7400 |
| UCB | 1 | The data contributor or sponsor doesn't have the legal authority to provide the data | Add-on treatment for refractory focal-onset epilepsy: Individual Participant Data Network Meta-analysis | 7227 |
| Roche | 1 | Data Sharing is prohibited by the consent, legal, regulatory, or contractual constraints on data sharing | Predictors of therapeutic and adverse effects of medicines used in the treatment of breast cancer | 6499 |
| AstraZeneca | 1 | Document not available in English | Longitudinal peripheral blood markers as dynamic predictors to identify efficacy and safety of non–small-cell lung cancer (NSCLC) patients treated with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) | 6629 |
| Pfizer | 1 | Out of scope since the indication is not approved in US or EU | SPondyloarthritis EARly Definition (ASAS-SPEAR) Analysis of Symptom Duration Thresholds Using Pooled Data from Randomized Controlled Trials | 7828 |
| Pfizer | 1 | The data requested is unavailable | SPondyloarthritis EARly Definition (ASAS-SPEAR) Analysis of Symptom Duration Thresholds Using Pooled Data from Randomized Controlled Trials | 7828 |
| Takeda | 1 | The data requested is not appropriate for the research proposal in the Data Request | The prognostic value of faecal calprotectin for long-term outcomes in ulcerative colitis | 8266 |
| Pfizer | 1 | The Data Requested is out of scope of data sharing policy | Addressing the synergistic effect of metformin in patients with Pancreatic neuroendocrine tumors treated with sunitinib: a post-hoc analysis from the main pivotal trials. | 7874 |
| Roche | 1 | Studies where data sharing is prohibited by the consent, legal, regulatory, or contractual constraints on data sharing | Organ-specific metastatic landscape dissects programmed death ligand-1 (PD-L1) blockade efficacy in advanced cancer | 8557 |
| Pfizer | 1 | Out of scope for data sharing because the indication is not approved in US or EU | Systemic pharmacological treatments for chronic plaque psoriasis: A Systematic Review and an Individual-Patient Data Network Meta-Analysis of Randomized Controlled Trials | 7620 |
| GlaxoSmithKline | 5 | Clinical studies where data labels and/or supporting documents are not in English | Heterogenous Effects in Diabetes Mellitus Clinical Trials and Implications for Physician Prescriptions | 7759 |
| Pfizer | 4 | The data contributor or sponsor doesn't have the legal authority to provide the data | Randomized Controlled Trial Data Availability and Re-Analysis Project | 7401 |
| Bristol Myers Squibb | 3 | The Data Requested is out of scope of data sharing policy | Longitudinal peripheral blood markers as dynamic predictors to identify efficacy and safety of patients treated with immune checkpoint inhibitors (ICIs) | 6762 |
| Pfizer | 2 | The Data requested is unavailable | Validating a Personalised Ankylosing Spondylitis Metrology Index | 8576 |
| AstraZeneca | 3 | The data requested is not appropriate for the research proposal in the Data Request | Clinical and molecular characteristics of hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) breast cancer a meta-analysis | 8842 |
| AstraZeneca | 6 | The data requested is not appropriate for the research proposal in the Data Request | The impact of human epidermal growth factor receptor 2-low (HER2-low) Expression on the Efficacy of endocrine therapy in Hormone Receptor-positiveHER2-Negative (HR+HER2-) Breast Cancer | 8856 |
| Boehringer ingelheim | 1 | The Data Request competes with the data contributor/sponsor's publication plan | The impact of malnutrition on the Efficacy and Safety of empagliflozin for heart failure With reduced ejection fraction | 8850 |
| Biogen | 1 | The data cannot be shared due to ongoing regulatory activities; | Monitoring of upper extremity motor function in Multiple Sclerosis the nine-hole-peg-test in MS revisited | 9132 |
| Bayer | 2 | The data requested cannot be shared due to ongoing regulatory activities | Loop Diuretics and Weight Change in Heart Failure: A Meta-Analysis | 9137 |
| Roche | 42 | The Data Request required data that was not collected in the studies requested; The data requested cannot be shared due to ongoing regulatory activities | Health-Related Quality of Life in Breast Cancer Clinical Trials Through the Lens of Race and Ethnicity: The Importance of Understanding the Patient Experience | 9230 |
| Boehringer ingelheim | 6 | The data requested is not appropriate for the research proposal in the Data Request | Health-Related Quality of Life in Breast Cancer Clinical Trials Through the Lens of Race and Ethnicity: The Importance of Understanding the Patient Experience | 9230 |
| AstraZeneca | 17 | Studies are out of scope of our policy; Studies do not meet the study criteria for the planned research project;The Data requested is unavailable | Health-Related Quality of Life in Breast Cancer Clinical Trials Through the Lens of Race and Ethnicity: The Importance of Understanding the Patient Experience | 9230 |
| Sanofi | 1 | Study does not meet the study criteria for the planned research project | Health-Related Quality of Life in Breast Cancer Clinical Trials Through the Lens of Race and Ethnicity: The Importance of Understanding the Patient Experience | 9230 |
| Bristol Myers Squibb | 4 | Out of Scope of Data Contributor’s Data Sharing Policy | Randomized Controlled Trial Data Availability and Re-Analysis Project | 7401 |
| Duke University | 1 | The Data Request required data that was not collected in the studies | Identifying Subgroups of Patients with Improved Outcomes in Clinical Trials | 9106 |
| AstraZeneca | 1 | Data collected subject to legal, contractual or consent provisions that prevent further sharing of clinical data | Identifying Subgroups of Patients with Improved Outcomes in Clinical Trials | 9106 |
